JNBA Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JNBA Financial Advisors's XBI Position: Q1 2026 in Review
JNBA Financial Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 41 shares — an estimated $5K sold.
JNBA Financial Advisors first reported a position in XBI in Q2 2016 and held it in 23 quarters. The position peaked at $43K in Q4 2020. 816 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- JNBA Financial Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
- JNBA Financial Advisors sold 41 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $5K.
- JNBA Financial Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and held it in 23 quarters.
- JNBA Financial Advisors's State Street SPDR S&P Biotech ETF position peaked at $43K in Q4 2020.
- 816 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on JNBA Financial Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.